Pyxis Oncology, Inc. (PYXS) — Dilution Risk Analysis

Current Snapshot

Pyxis Oncology, Inc. (PYXS) has a DilutionWatch score of 76/10 and is classified as CRITICAL risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
83,408,050 Source
Public Float
40,396,722 Source
Float as % of Outstanding
48.4%

Dilution Risk Score

Score: 76/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: XBRL 1, 4 9.

FormFiledAccession
xbrl 2026-06-30 xbrl-5561-xbrl_warrant
4 2026-03-25 0000905148-26-001434
4 2026-03-25 0001193125-26-124313
4 2026-03-25 0001193125-26-124319
4 2026-03-25 0001193125-26-124325
4 2026-03-25 0001193125-26-124333
4 2026-03-25 0001193125-26-124342
4 2026-03-25 0001193125-26-124348
4 2026-03-25 0001193125-26-124380
4 2026-03-25 0001193125-26-124388

Dilution Risk Drivers

DriverStored ValueSource
Cash runway 4 months Source
Three-year share count growth 88.18% Source

DilutionWatch Analysis

Risk Level
CRITICAL (Score: 76/10) Source
Cash Runway
4 months Source
Share Count Growth (3-Year)
88.18% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.